RSV and Influenza during the COVID-19 pandemic - a two-center experience

RSV and Influenza during the COVID-19 pandemic - a two-center experience - RICO

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00028016

Enrollment

600

Registered

2022-02-24

Start date

2022-03-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J12.1 J20.5 B97.4 J10.1

Interventions

Group 1: Determine RSV (respiratory syncytial virus) and Influenza disease during the Covid-19 pandemic at two Austrian urban pediatric centers “SMZ OST Wien and Universitätsklinikum Graz” between Sep

Eligibility

Sex/Gender

All

Age

1 Days to 18 Years

Inclusion criteria

Inclusion criteria: According to ICD-10 classification J12.1, J20.5, J21.0 and B97.4 hospitalization associated with RSV infection within the study period, presence of respiratory symptoms, and proven RSV disease by either positive PCR or antigen test. For Influenza infection J10.1 and hospitalization during the study period, presence of respiratory symptoms and proven Influenza disease by either positive PCR or antigen test.

Exclusion criteria

Exclusion criteria: RSV or Influenza not proven or hospitalization due to other than respiratory disease. Nosocomial RSV infections will separately be analyzed.

Design outcomes

Primary

Measure	Time frame
The aim of the study is to determine RSV and Influenza disease during the Covid-19 pandemic at two Austrian urban pediatric centers “SMZ OST Wien and Universitätsklinikum Graz” between Sept 1, 2019 and Dec 17, 2021.	—

Secondary

Measure	Time frame
-Severity of RSV and Influenza disease measured by length of stay due to infectious disease, supplemental oxygen therapy and rates of ICU admission with need of non-invasive and invasive respiratory support. -To describe the clinical course as well as complications and treatments -To analyze the demographic, seasonality and medical background of RSV and Influenza hospitalization cases -To identify risk factors -To compare the clinical course of RSV/Influenza hospitalization during the 1st year and within older children -To compare all disease parameters between the two pediatric centers	—

Measure

Time frame

-Severity of RSV and Influenza disease measured by length of stay due to infectious disease, supplemental oxygen therapy and rates of ICU admission with need of non-invasive and invasive respiratory support. -To describe the clinical course as well as complications and treatments -To analyze the demographic, seasonality and medical background of RSV and Influenza hospitalization cases -To identify risk factors -To compare the clinical course of RSV/Influenza hospitalization during the 1st year and within older children -To compare all disease parameters between the two pediatric centers

—

Countries

Austria

Contacts

Public ContactBernhard Resch

Universitätsklinikum für Kinder- und Jugendheilkunde Graz, Abteilung für Neonatologie

bernhard.resch@medunigraz.at+43/316/ 385-81134

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026